David Meek is the founder of FerGene. FerGene has raised $570M in total funding. Backed by Ferring Pharmaceuticals, Blackstone Life Sciences.
David Meek transitioned from Ipsen to become the CEO of FerGene, a gene therapy spinout launched by Ferring Pharmaceuticals and Blackstone Life Sciences. He is leading the company's efforts to develop and commercialize nadofaragene firadenovec, a gene therapy for bladder cancer.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide